StockMarketWire.com - HSBC today reaffirms its hold investment rating on Dechra Pharmaceuticals PLC [LON:DPH] and raised its price target to 2950p (from 2915p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk